Clinical trials
Agnosia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 5 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Becton, Dickinson and Company | 2 |
| Hospital Clinic of Barcelona | 2 |
| Hospital Universitario Virgen Macarena | 2 |
| Hospital Universitario de Gran Canaria Doctor Negrín | 2 |
| Universidad Autonoma de Madrid | 2 |
| Universidad de Granada | 2 |
| Badalona Serveis Assistencials | 1 |
| Centro Universitario La Salle | 1 |
| Clinica Gema Leon | 1 |
| Complejo Hospitalario de Toledo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agnosia | 50 |
| Pain | 18 |
| Postoperative Pain | 7 |
| Chronic Pain | 4 |
| Anxiety Disorders | 2 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
| Musculoskeletal Diseases | 2 |
| Abdominal Injuries | 1 |
| Acute Pain | 1 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.